Alphatec CEO Miles Patrick Purchases 115,000 Shares for $1 Million. Is the Medical Tech Stock Now a Buy?
Patrick's purchase brings his total beneficial ownership to 6.2 million shares worth $54.41 million, signaling confidence despite the stock's 42% decline over the past year.
Alphatec Holdings, Inc., a medical device manufacturer, saw its CEO Miles Patrick buy approximately 115,000 shares of the company's common stock on September 10, 2026, according to a recent SEC Form 4 filing. The transaction, valued at $1 million based on the weighted average purchase price of $8.81 per share, came shortly after the stock closed at $8.84 that day.
Alphatec, which operates in the specialized field of spinal condition management, reported $815.1 million in trailing twelve-month revenue and employs 913 people. With a market capitalization of $1.3 billion, the company is a significant player in the spinal surgery market, leveraging its proprietary intraoperative neuromonitoring technology and integrated surgical access systems to enhance procedural safety and clinical outcomes.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
